2nd International Congress of the World Muscle Society, Tunis, 16-18 October 1997: The role of immunocytochemistry in congenital myopathies

Neuromuscular Disorders

Volumn 8, Issue 6, 1998, Pages 394-400

  Sewry, C A ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Central core disease; Centronuclear myopathy; Congenital myopathy; Immunocytochemistry; Myotubular myopathy; Nemaline myopathy

Indexed keywords

MYOSIN HEAVY CHAIN; NEBULIN; RYANODINE RECEPTOR;

CONFERENCE PAPER; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; INTERMEDIATE FILAMENT; MYOPATHY; NEMALINE MYOPATHY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; IMMUNOHISTOCHEMISTRY; MUSCLE DISEASE; REVIEW;

HUMANS; IMMUNOHISTOCHEMISTRY; MUSCULAR DISEASES; MYOPATHIES, NEMALINE;

EID: 0032133989     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00053-4     Document Type: Conference Paper

References (22)

1. [1] Campbell KP. Three muscular dystrophies: loss of cytoskeletal-extracellular matrix linkage. Cell 1995;80:675-679.
2. [2] Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1995;4:1711-1716.
3. [3] Sewry CA, Taylor J, Anderson LVB, et al. Abnormalities in α-, β, and γ-sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromusc Disord 1996;6:467-474.
4. [4] Manilal S, Nguyen thi Man, Sewry CA, Morris GE. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 1996;5:801-808.
5. [5] Sewry CA, Dubowitz V. Histochemical and immunocytochemical studies in neuromuscular diseases. In: Walton J, Karpati G, Hilton-Jones, D, editors. Disorders of voluntary muscle, 6th edition. Edinburgh: Churchill Livingstone, 1994:261-318.
6. [6] Wallgren-Pettersson C, Laing N. Report on 40th ENMC Workshop on Nemaline Myopathy. February 1996 Naarden. Neuromusc Disord 1996;6:389-391.
7. [7] Laing N, Majda B, Akkari P, et al. Assignment of a gene (NEM1) for autosomal dominant nemaline myopathy to chromosome 1. Nature 1992;50:576-583.
8. [8] Tan P, Briner J, Bolsthauser E, et al. Homozygosity for a nonsense mutation in the alpha-tropomyosin gene TPM3 in a patient with severe nemaline myopathy. Neuromusc Disord 1997;7:427 (abstract).
9. [9] Wallgren-Pettersson C, Avela K, Marchand S, et al. A gene for autosomal recessive nemaline myopathy assigned to chromosome 2q by linkage analysis. Neuromusc Disord 1995;5:441-443.
10. [10] Wood DS, Zeviani M, Prelle A. Is nebulin the defective gene product in Duchenne muscular dystrophy?. New Eng J Med 1987;316:107-108.
11. [11] Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76:371-423.
12. [12] Schollmeyer JV, Goll D, Stromer MH, Dayton W, Singh I, Robson RM. Studies on the composition of the Z disk. J Cell Biol 1974;63:303.
13. [13] Jockusch B, Veldman H, Griffiths GW, van Oost BA, Jennekens FGI. Immunofluorescence microscopy of a myopathy. α-Actinin is a major constituent of nemaline rods. Exp Cell Res 1980;127:409-420.
14. [14] Yamaguchi M, Robson RM, Stromer MH, Dahl DS, Oda T. Nemaline myopathy rod bodies: structure and composition. J Neurol Sci 1982;56:35-56.
15. [15] Thornell L-E, Edström L, Eriksson A, Henriksson K-G, Angqvist KA. The distribution of intermediate filaments protein (skeletin) in normal and diseased human skeletal muscle. J Neurol Sci 1980; 47:153-170.
16. [16] North K, Beggs A. Deficiency of skeletal muscle isoforms of α-actinin (α-actinin-3) in merosin positive congenital muscular dystrophy. Neuromusc Disord 1996;6:229-235.
17. [17] Thornell L-E, Eriksson A, Edström L. Intermediate filaments in human myopathies. In: Dowben RM, Shay JW, editors. Cell and muscle motility, vol 4. Plenum, New York (London)1983:85-136.
18. [18] Laporte J, Hu LJ, Kretz C, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 1995;15:175-182.
19. [19] Spiro AJ, Shy GM, Gonatas NK. Myotubular myopathy. Arch Neurol (Chicago) 1966;14:1-14.
20. [20] Sarnat HB. Myotubular myopathy: arrest of myofibres associated with persistence of fetal vimentin and desmin. Four cases compared with fetal and neonatal muscle. Can J Neurol Sci 1991;17:109-123.
21. [21] Zhang Y, Chen HS, Khanna VK, et al. A mutation in the human ryanodine receptor gene associated with central core disease. Nat Genet 1993;5:46-50.
22. [22] Sewry CA. Ultrastructural changes in diseased muscle. In Dubowitz V, Muscle biopsy: a practical approach, 2nd edition. London: Baillière Tindall, 1985:129-183.